Oxycodone Teva Sweden (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodone Teva Sweden, is an opioid analgesic presented as a strength‑unknown tablet for oral use. It is prescribed for the management of moderate to severe pain in adult patients when other analgesics are insufficient.

GNH USA supplies Oxycodone Teva Sweden as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone acts on the central nervous system to relieve pain of various origins. - Acute postoperative pain: provides strong analgesia during the recovery period after surgery. - Cancer‑related pain: helps control persistent pain associated with malignant disease. - Severe chronic non‑cancer pain: reduces pain intensity when other treatments have failed.

Adverse reactions may range from mild to life‑threatening and should be monitored closely.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: feeling of queasiness often accompanied by vomiting. - Drowsiness: increased sleepiness or sedation. - Dizziness: light‑headed sensation, especially when standing. - Dry mouth: reduced salivation. - Sweating: increased perspiration without exertion.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Severe hypotension: marked drop in blood pressure. - Opioid dependence or addiction: compulsive use despite harmful consequences. - Seizures: rare occurrence of convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - Adrenal insufficiency: impaired cortisol production.

When prescribing Oxycodone, clinicians should evaluate patient history and monitor for adverse effects. - Assess pain severity and treatment goals: ensure opioid therapy is appropriate. - Review respiratory function: patients with compromised breathing need close observation. - Evaluate renal and hepatic function: dose adjustments may be required in impairment. - Counsel on sedation and driving: patients should avoid operating machinery while impaired. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Oxycodone may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Concomitant use with CNS depressants: increased risk of respiratory depression and profound sedation. - MAO inhibitors: may precipitate severe hypertension or serotonin syndrome.\nModerate Interactions (Monitor Closely): - Benzodiazepines: additive sedative effects require dose titration. - Antidepressants (SSRIs, SNRIs): may increase serotonin levels and risk of serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole): raise oxy‑receptor . - CYP